Key Financial Data Of Reporting Company

Daito Pharmaceutical Co., Ltd. - Filing #7569991

Concept As at
2023-02-28
2022-12-01 to
2023-02-28
2022-06-01 to
2023-02-28
2021-06-01 to
2022-05-31
As at
2022-05-31
2021-12-01 to
2022-02-28
2021-06-01 to
2022-02-28
As at
2022-02-28
Key financial data of reporting company
Business results of reporting company
Net sales
34,570,000,000 JPY
43,464,000,000 JPY
33,583,000,000 JPY
Ordinary profit (loss)
4,077,000,000 JPY
6,729,000,000 JPY
5,794,000,000 JPY
Net assets
49,851,000,000 JPY
47,674,000,000 JPY
46,304,000,000 JPY
Total assets
68,602,000,000 JPY
64,939,000,000 JPY
62,679,000,000 JPY
Basic earnings (loss) per share
62.52
184.98
335.41
85.76
287.81
Diluted earnings per share
184.76
Equity-to-asset ratio
0.722 xbrli:pure
0.728 xbrli:pure
0.733 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.